AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: CRGO
Report Date: 2026-04-14
Full Report: https://amaly.io/stock/CRGO

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: BB
Description: Cargo Therapeutics, Inc. (CRGO) is a clinical-stage biotechnology company focused on developing CAR T-cell therapies for cancer patients. The company demonstrates strong financial compliance with low debt levels, acceptable liquidity, and minimal non-permissible income. However, due to its small market capitalization and recent IPO status, it is not yet included in major Shariah-compliant indices. Business activities in oncology research are permissible under Shariah principles. Overall, while ratios support compliance, index exclusion leads to a non-compliant classification pending growth.

Primary Compliance Concerns:
- Exclusion from major Shariah indices due to small market cap and liquidity requirements
- Limited historical data for trend analysis

Purification Requirement: 4.49%
Index Inclusion: Not included in S&P Dow Jones Shariah, MSCI Islamic, FTSE Shariah, or DJIM indices

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 0.0%
Interest Income Ratio: 0.0%
Purification Required: 4.49%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2026-01-31

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-24T12:00:00Z

---
Full interactive report: https://amaly.io/stock/CRGO
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.